Dimidjian Sona, Goodman Sherryl H, Felder Jennifer N, Gallop Robert, Brown Amanda P, Beck Arne
Department of Psychology and Neuroscience, University of Colorado Boulder.
Department of Psychology, Emory University.
J Consult Clin Psychol. 2016 Feb;84(2):134-45. doi: 10.1037/ccp0000068. Epub 2015 Dec 14.
Clinical decision-making regarding the prevention of depression is complex for pregnant women with histories of depression and their health care providers. Pregnant women with histories of depression report preference for nonpharmacological care, but few evidence-based options exist. Mindfulness-based cognitive therapy has strong evidence in the prevention of depressive relapse/recurrence among general populations and indications of promise as adapted for perinatal depression (MBCT-PD). With a pilot randomized clinical trial, our aim was to evaluate treatment acceptability and efficacy of MBCT-PD relative to treatment as usual (TAU).
Pregnant adult women with depression histories were recruited from obstetric clinics at 2 sites and randomized to MBCT-PD (N = 43) or TAU (N = 43). Treatment acceptability was measured by assessing completion of sessions, at-home practice, and satisfaction. Clinical outcomes were interview-based depression relapse/recurrence status and self-reported depressive symptoms through 6 months postpartum.
Consistent with predictions, MBCT-PD for at-risk pregnant women was acceptable based on rates of completion of sessions and at-home practice assignments, and satisfaction with services was significantly higher for MBCT-PD than TAU. Moreover, at-risk women randomly assigned to MBCT-PD reported significantly improved depressive outcomes compared with participants receiving TAU, including significantly lower rates of depressive relapse/recurrence and lower depressive symptom severity during the course of the study.
MBCT-PD is an acceptable and clinically beneficial program for pregnant women with histories of depression; teaching the skills and practices of mindfulness meditation and cognitive-behavioral therapy during pregnancy may help to reduce the risk of depression during an important transition in many women's lives.
对于有抑郁症病史的孕妇及其医疗服务提供者而言,预防抑郁症的临床决策十分复杂。有抑郁症病史的孕妇表示更倾向于非药物治疗,但基于证据的选择很少。基于正念的认知疗法在预防普通人群抑郁复发/再发方面有充分证据,且有迹象表明其适用于围产期抑郁症(MBCT-PD)。通过一项试点随机临床试验,我们旨在评估MBCT-PD相对于常规治疗(TAU)的治疗可接受性和疗效。
从两个地点的产科诊所招募有抑郁症病史的成年孕妇,随机分为MBCT-PD组(N = 43)或TAU组(N = 43)。通过评估课程完成情况、家庭练习情况和满意度来衡量治疗可接受性。临床结局包括基于访谈的抑郁复发/再发状态以及产后6个月自我报告的抑郁症状。
与预测一致,基于课程完成率和家庭练习任务完成率,针对有风险的孕妇的MBCT-PD是可接受的,且MBCT-PD组对服务的满意度显著高于TAU组。此外,与接受TAU的参与者相比,随机分配到MBCT-PD组的有风险女性报告的抑郁结局有显著改善,包括在研究过程中抑郁复发/再发率显著降低以及抑郁症状严重程度更低。
MBCT-PD对于有抑郁症病史的孕妇是一种可接受且具有临床益处的方案;在孕期教授正念冥想和认知行为疗法的技巧和实践可能有助于降低许多女性生命中这一重要过渡时期的抑郁风险。